(Q37903224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Use of inflammatory markers to guide cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

S J Clarke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

W Chua

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Moore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Kao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

V Phan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Tan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Charles

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

20 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

475-478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Inflammation and cancer: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

The causes and consequences of cancer-associated malnutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Definition and classification of cancer cachexia: an international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Oral morphine and respiratory function amongst hospice inpatients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Predicting the toxicity of weekly docetaxel in advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.122

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775983%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference